Please Wait.....
Report
Mexoryl SX (Ecamsule) Market By Purity Level (Less than 98%, More than 98%), By Application (Cosmetics, Pharmaceuticals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2022-07-01 I 199 Pages I Allied Market Research
The global mexoryl SX (ecamsule) market was valued at $49.5 million in 2021, and is projected to reach $82.6 million by 2031, growing at a CAGR of 5.3% from 2022 to 2031.
Mexoryl SX is the trade name for ecamsule, or terephthalylidene dicamphor sulfonic acid. It is an organic sun filter (carbon-based) developed and patented by L'Oreal in 1982. It protects mainly against UVA rays, the main cause of premature skin aging and skin cancers. In addition, it is used as a photostable drug that resists the formation of UV induced pyrimidine dimers and delays the onset of skin cancer.
The increasing awareness toward skincare, beauty, and lifestyle has surged the demand for personal care & cosmetic products where mexoryl SX (ecamsule) protects skin mainly from long wave ultraviolet A (UVA) rays that is the main cause of premature skin aging and skin cancers. This may propel the growth of the mexoryl SX) ecamsule) market. In addition, rise in concerns about skin protection against detrimental rays of the sun and improved alertness regarding skin cancer have led the customers become more linear toward using mexoryl SX (ecamsule)-based sunscreens, which fosters the growth of the mexoryl SX (ecamsule) market.
However, mexoryl SX (ecamsule) is a newly developed product and is relatively new in the market. It requires certain testing and approvals for its adoption among various end use applications. For instance, food and drug administration (FDA) is proposing to prevent the use of ecamsule and anzacamene in sunscreens due to their ineffectiveness. Thus, FDA's action means that Americans may not have access to these products. This factor may hamper the growth of the mexoryl SX (ecamsule) market during the forecast period.
On the contrary, surge in R&D activities for developing a broad spectrum of sunscreens formulation where mexoryl SX (ecamsule) is widely used for photo-protection purposes in all skin types may create new opportunities for the market.
The mexoryl SX (ecamsule) market is segmented into purity level, application, and region. On the basis of purity level, the market is segregated into less than 98% and more than 98%. Depending on application, it is fragmented into cosmetics, phamraceuticals, and others. Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
The leading players operating in the global mexoryl SX (ecamsule) market include Biosynth Carbosynth, ChemScene LLC, Derma Company, National Analytical Corporation, Norna Technology Co., Skylead Pharmaceuticals & Chemicals, L'Oreal S.A., and MFCI CO.,LTD (Hubei Meifeng Chemical Co., Ltd.).The global mexoryl SX (ecamsule) market report provides in-depth competitive analysis as well as profiles of these major players.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the mexoryl sx (ecamsule) market analysis from 2021 to 2031 to identify the prevailing mexoryl sx (ecamsule) market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the mexoryl sx (ecamsule) market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global mexoryl sx (ecamsule) market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Purity Level
- Less than 98%
- More than 98%
By Application
- Cosmetics
- Pharmaceuticals
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Australia
- Rest of Asia-Pacific
- China
- India
- Japan
- South Korea
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- L'Oreal S.A.
- Skylead Pharmaceuticals & Chemicals
- ChemScene LLC
- Biosynth Carbosynth
- NATIONAL ANALYTICAL CORPORATION
- Norna Technology Co.
- Derma Companies
- MFCI CO.,LTD
- Merck KGaA
- Parchem Fine and Specialty Chemicals
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Pricing Analysis
3.8.Value Chain Analysis
3.9.Key Regulation Analysis
3.10.Patent Landscape
CHAPTER 4: MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL
4.1 Overview
4.1.1 Market size and forecast
4.2 Less than 98%
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 More than 98%
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Cosmetics
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Pharmaceuticals
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: MEXORYL SX (ECAMSULE) MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Purity Level
6.2.3 North America Market size and forecast, by Application
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Purity Level
6.2.4.1.2 Market size and forecast, by Application
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Purity Level
6.2.4.2.2 Market size and forecast, by Application
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Purity Level
6.2.4.3.2 Market size and forecast, by Application
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Purity Level
6.3.3 Europe Market size and forecast, by Application
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Purity Level
6.3.4.1.2 Market size and forecast, by Application
6.3.4.2 United Kingdom
6.3.4.2.1 Market size and forecast, by Purity Level
6.3.4.2.2 Market size and forecast, by Application
6.3.4.3 France
6.3.4.3.1 Market size and forecast, by Purity Level
6.3.4.3.2 Market size and forecast, by Application
6.3.4.4 Spain
6.3.4.4.1 Market size and forecast, by Purity Level
6.3.4.4.2 Market size and forecast, by Application
6.3.4.5 Italy
6.3.4.5.1 Market size and forecast, by Purity Level
6.3.4.5.2 Market size and forecast, by Application
6.3.4.6 Rest of Europe
6.3.4.6.1 Market size and forecast, by Purity Level
6.3.4.6.2 Market size and forecast, by Application
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Purity Level
6.4.3 Asia-Pacific Market size and forecast, by Application
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Market size and forecast, by Purity Level
6.4.4.1.2 Market size and forecast, by Application
6.4.4.2 India
6.4.4.2.1 Market size and forecast, by Purity Level
6.4.4.2.2 Market size and forecast, by Application
6.4.4.3 Japan
6.4.4.3.1 Market size and forecast, by Purity Level
6.4.4.3.2 Market size and forecast, by Application
6.4.4.4 South Korea
6.4.4.4.1 Market size and forecast, by Purity Level
6.4.4.4.2 Market size and forecast, by Application
6.4.4.5 Australia
6.4.4.5.1 Market size and forecast, by Purity Level
6.4.4.5.2 Market size and forecast, by Application
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Market size and forecast, by Purity Level
6.4.4.6.2 Market size and forecast, by Application
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Purity Level
6.5.3 LAMEA Market size and forecast, by Application
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Market size and forecast, by Purity Level
6.5.4.1.2 Market size and forecast, by Application
6.5.4.2 Saudi Arabia
6.5.4.2.1 Market size and forecast, by Purity Level
6.5.4.2.2 Market size and forecast, by Application
6.5.4.3 South Africa
6.5.4.3.1 Market size and forecast, by Purity Level
6.5.4.3.2 Market size and forecast, by Application
6.5.4.4 Rest of LAMEA
6.5.4.4.1 Market size and forecast, by Purity Level
6.5.4.4.2 Market size and forecast, by Application
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 L'Oreal S.A.
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Skylead Pharmaceuticals & Chemicals
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 ChemScene LLC
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Biosynth Carbosynth
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 NATIONAL ANALYTICAL CORPORATION
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Norna Technology Co.
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Derma Companies
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 MFCI CO.,LTD
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Merck KGaA
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Parchem Fine and Specialty Chemicals
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 2. GLOBAL MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 3. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR LESS THAN 98%, BY REGION, 2021-2031 ($MILLION)
TABLE 4. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR LESS THAN 98%, BY REGION, 2021-2031 (TONS)
TABLE 5. MEXORYL SX (ECAMSULE) MARKET FOR LESS THAN 98%, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. MEXORYL SX (ECAMSULE) MARKET FOR LESS THAN 98%, BY COUNTRY, 2021-2031 (TONS)
TABLE 7. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR MORE THAN 98%, BY REGION, 2021-2031 ($MILLION)
TABLE 8. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR MORE THAN 98%, BY REGION, 2021-2031 (TONS)
TABLE 9. MEXORYL SX (ECAMSULE) MARKET FOR MORE THAN 98%, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. MEXORYL SX (ECAMSULE) MARKET FOR MORE THAN 98%, BY COUNTRY, 2021-2031 (TONS)
TABLE 11. GLOBAL MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 12. GLOBAL MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 13. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR COSMETICS, BY REGION, 2021-2031 ($MILLION)
TABLE 14. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR COSMETICS, BY REGION, 2021-2031 (TONS)
TABLE 15. MEXORYL SX (ECAMSULE) MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 16. MEXORYL SX (ECAMSULE) MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 (TONS)
TABLE 17. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR PHARMACEUTICALS, BY REGION, 2021-2031 ($MILLION)
TABLE 18. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR PHARMACEUTICALS, BY REGION, 2021-2031 (TONS)
TABLE 19. MEXORYL SX (ECAMSULE) MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. MEXORYL SX (ECAMSULE) MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2021-2031 (TONS)
TABLE 21. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 22. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 (TONS)
TABLE 23. MEXORYL SX (ECAMSULE) MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 24. MEXORYL SX (ECAMSULE) MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (TONS)
TABLE 25. MEXORYL SX (ECAMSULE) MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 26. MEXORYL SX (ECAMSULE) MARKET, BY REGION, 2021-2031 (TONS)
TABLE 27. NORTH AMERICA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 28. NORTH AMERICA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 29. NORTH AMERICA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 30. NORTH AMERICA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 31. NORTH AMERICA MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. NORTH AMERICA MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 33. U.S. MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 34. U.S. MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 35. U.S. MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 36. U.S. MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 37. CANADA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 38. CANADA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 39. CANADA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 40. CANADA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 41. MEXICO MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 42. MEXICO MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 43. MEXICO MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. MEXICO MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 45. EUROPE MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 46. EUROPE MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 47. EUROPE MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 48. EUROPE MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 49. EUROPE MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 50. EUROPE MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 51. GERMANY MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 52. GERMANY MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 53. GERMANY MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 54. GERMANY MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 55. UNITED KINGDOM MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 56. UNITED KINGDOM MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 57. UNITED KINGDOM MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 58. UNITED KINGDOM MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 59. FRANCE MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 60. FRANCE MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 61. FRANCE MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 62. FRANCE MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 63. SPAIN MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 64. SPAIN MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 65. SPAIN MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. SPAIN MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 67. ITALY MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 68. ITALY MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 69. ITALY MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. ITALY MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 71. REST OF EUROPE MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 72. REST OF EUROPE MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 73. REST OF EUROPE MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 74. REST OF EUROPE MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 75. ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 76. ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 77. ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 78. ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 79. ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 80. ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 81. CHINA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 82. CHINA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 83. CHINA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 84. CHINA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 85. INDIA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 86. INDIA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 87. INDIA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 88. INDIA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 89. JAPAN MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 90. JAPAN MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 91. JAPAN MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 92. JAPAN MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 93. SOUTH KOREA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 94. SOUTH KOREA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 95. SOUTH KOREA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 96. SOUTH KOREA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 97. AUSTRALIA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 98. AUSTRALIA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 99. AUSTRALIA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 100. AUSTRALIA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 101. REST OF ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 102. REST OF ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 103. REST OF ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 104. REST OF ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 105. LAMEA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 106. LAMEA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 107. LAMEA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 108. LAMEA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 109. LAMEA MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 110. LAMEA MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 111. BRAZIL MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 112. BRAZIL MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 113. BRAZIL MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 114. BRAZIL MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 115. SAUDI ARABIA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 116. SAUDI ARABIA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 117. SAUDI ARABIA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 118. SAUDI ARABIA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 119. SOUTH AFRICA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 120. SOUTH AFRICA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 121. SOUTH AFRICA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 122. SOUTH AFRICA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 123. REST OF LAMEA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
TABLE 124. REST OF LAMEA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
TABLE 125. REST OF LAMEA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 126. REST OF LAMEA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 127.L'OREAL S.A.: COMPANY SNAPSHOT
TABLE 128.L'OREAL S.A.: OPERATING SEGMENTS
TABLE 129.L'OREAL S.A.: PRODUCT PORTFOLIO
TABLE 130.L'OREAL S.A.: NET SALES,
TABLE 131.L'OREAL S.A.: KEY STRATERGIES
TABLE 132.SKYLEAD PHARMACEUTICALS & CHEMICALS: COMPANY SNAPSHOT
TABLE 133.SKYLEAD PHARMACEUTICALS & CHEMICALS: OPERATING SEGMENTS
TABLE 134.SKYLEAD PHARMACEUTICALS & CHEMICALS: PRODUCT PORTFOLIO
TABLE 135.SKYLEAD PHARMACEUTICALS & CHEMICALS: NET SALES,
TABLE 136.SKYLEAD PHARMACEUTICALS & CHEMICALS: KEY STRATERGIES
TABLE 137.CHEMSCENE LLC: COMPANY SNAPSHOT
TABLE 138.CHEMSCENE LLC: OPERATING SEGMENTS
TABLE 139.CHEMSCENE LLC: PRODUCT PORTFOLIO
TABLE 140.CHEMSCENE LLC: NET SALES,
TABLE 141.CHEMSCENE LLC: KEY STRATERGIES
TABLE 142.BIOSYNTH CARBOSYNTH: COMPANY SNAPSHOT
TABLE 143.BIOSYNTH CARBOSYNTH: OPERATING SEGMENTS
TABLE 144.BIOSYNTH CARBOSYNTH: PRODUCT PORTFOLIO
TABLE 145.BIOSYNTH CARBOSYNTH: NET SALES,
TABLE 146.BIOSYNTH CARBOSYNTH: KEY STRATERGIES
TABLE 147.NATIONAL ANALYTICAL CORPORATION: COMPANY SNAPSHOT
TABLE 148.NATIONAL ANALYTICAL CORPORATION: OPERATING SEGMENTS
TABLE 149.NATIONAL ANALYTICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 150.NATIONAL ANALYTICAL CORPORATION: NET SALES,
TABLE 151.NATIONAL ANALYTICAL CORPORATION: KEY STRATERGIES
TABLE 152.NORNA TECHNOLOGY CO.: COMPANY SNAPSHOT
TABLE 153.NORNA TECHNOLOGY CO.: OPERATING SEGMENTS
TABLE 154.NORNA TECHNOLOGY CO.: PRODUCT PORTFOLIO
TABLE 155.NORNA TECHNOLOGY CO.: NET SALES,
TABLE 156.NORNA TECHNOLOGY CO.: KEY STRATERGIES
TABLE 157.DERMA COMPANIES: COMPANY SNAPSHOT
TABLE 158.DERMA COMPANIES: OPERATING SEGMENTS
TABLE 159.DERMA COMPANIES: PRODUCT PORTFOLIO
TABLE 160.DERMA COMPANIES: NET SALES,
TABLE 161.DERMA COMPANIES: KEY STRATERGIES
TABLE 162.MFCI CO.,LTD: COMPANY SNAPSHOT
TABLE 163.MFCI CO.,LTD: OPERATING SEGMENTS
TABLE 164.MFCI CO.,LTD: PRODUCT PORTFOLIO
TABLE 165.MFCI CO.,LTD: NET SALES,
TABLE 166.MFCI CO.,LTD: KEY STRATERGIES
TABLE 167.MERCK KGAA: COMPANY SNAPSHOT
TABLE 168.MERCK KGAA: OPERATING SEGMENTS
TABLE 169.MERCK KGAA: PRODUCT PORTFOLIO
TABLE 170.MERCK KGAA: NET SALES,
TABLE 171.MERCK KGAA: KEY STRATERGIES
TABLE 172.PARCHEM FINE AND SPECIALTY CHEMICALS: COMPANY SNAPSHOT
TABLE 173.PARCHEM FINE AND SPECIALTY CHEMICALS: OPERATING SEGMENTS
TABLE 174.PARCHEM FINE AND SPECIALTY CHEMICALS: PRODUCT PORTFOLIO
TABLE 175.PARCHEM FINE AND SPECIALTY CHEMICALS: NET SALES,
TABLE 176.PARCHEM FINE AND SPECIALTY CHEMICALS: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.MEXORYL SX (ECAMSULE) MARKET SEGMENTATION
FIGURE 2.MEXORYL SX (ECAMSULE) MARKET,2021-2031
FIGURE 3.MEXORYL SX (ECAMSULE) MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.MEXORYL SX (ECAMSULE) MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.PRICING ANALYSIS
FIGURE 13.VALUE CHAIN ANALYSIS
FIGURE 14.KEY REGULATION ANALYSIS
FIGURE 15.PATENT ANALYSIS BY COMPANY
FIGURE 16.PATENT ANALYSIS BY COUNTRY
FIGURE 17.MEXORYL SX (ECAMSULE) MARKET,BY PURITY LEVEL,2021(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF LESS THAN 98% MEXORYL SX (ECAMSULE) MARKET,2021-2031(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF MORE THAN 98% MEXORYL SX (ECAMSULE) MARKET,2021-2031(%)
FIGURE 20.MEXORYL SX (ECAMSULE) MARKET,BY APPLICATION,2021(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF COSMETICS MEXORYL SX (ECAMSULE) MARKET,2021-2031(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICALS MEXORYL SX (ECAMSULE) MARKET,2021-2031(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF OTHERS MEXORYL SX (ECAMSULE) MARKET,2021-2031(%)
FIGURE 24.MEXORYL SX (ECAMSULE) MARKET BY REGION,2021
FIGURE 25.U.S. MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 26.CANADA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 27.MEXICO MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 28.GERMANY MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 29.UNITED KINGDOM MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 30.FRANCE MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 31.SPAIN MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 32.ITALY MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 33.REST OF EUROPE MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 34.CHINA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 35.INDIA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 36.JAPAN MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 37.SOUTH KOREA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 38.AUSTRALIA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 39.REST OF ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 40.BRAZIL MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 41.SAUDI ARABIA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 42.SOUTH AFRICA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 43.REST OF LAMEA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 47.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 48.COMPETITIVE DASHBOARD
FIGURE 49.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 50.L'OREAL S.A..: NET SALES ,($MILLION)
FIGURE 51.SKYLEAD PHARMACEUTICALS & CHEMICALS.: NET SALES ,($MILLION)
FIGURE 52.CHEMSCENE LLC.: NET SALES ,($MILLION)
FIGURE 53.BIOSYNTH CARBOSYNTH.: NET SALES ,($MILLION)
FIGURE 54.NATIONAL ANALYTICAL CORPORATION.: NET SALES ,($MILLION)
FIGURE 55.NORNA TECHNOLOGY CO..: NET SALES ,($MILLION)
FIGURE 56.DERMA COMPANIES.: NET SALES ,($MILLION)
FIGURE 57.MFCI CO.,LTD.: NET SALES ,($MILLION)
FIGURE 58.MERCK KGAA.: NET SALES ,($MILLION)
FIGURE 59.PARCHEM FINE AND SPECIALTY CHEMICALS.: NET SALES ,($MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security